Cordyceps protein alleviates renal injury by inhibiting T cell infiltration and Th1 cell differentiation in lupus nephritis mice

• Published in: International immunopharmacology Vol. 138; p. 112566
• Main Authors: Liao, Zhengyue, Yang, Xingmao, He, Liying, Bai, Jing, Zhou, Xiaotong, Yang, Jingyan, Niu, Shuqi, Liu, Sijing, Guo, Jinlin
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 10.09.2024
• Subjects: Animals; Cell Differentiation - drug effects; Chemokines; Cordyceps - chemistry; Cordyceps proteins; Cytokines - metabolism; Disease Models, Animal; Female; Humans; Kidney - drug effects; Kidney - immunology; Kidney - pathology; Lupus nephritis; Lupus Nephritis - drug therapy; Lupus Nephritis - immunology; Lupus Nephritis - pathology; Mice; Mice, Inbred MRL lpr; MRL/lpr mice; Th1 Cells - drug effects; Th1 Cells - immunology; Th1 differentiation; Th1 differentiation; Lupus nephritis; Cordyceps proteins; MRL/lpr mice; Chemokines
• ISSN: 1567-5769; 1878-1705; 1878-1705
• DOI: 10.1016/j.intimp.2024.112566

[Display omitted] •Cordyceps protein alleviates lupus nephritis by inhibiting Th1 cell differentiation.•Cordyceps protein attenuates renal cell infiltration in mice with lupus nephritis.•Cordyceps protein prevents T cell migration into the kidney to alleviate kidney injury in MRL/lpr mice. T cell infiltration and differentiation play a central part in the development of lupus nephritis (LN). Our prior research has indicated that protein, the primary active component of cordyceps (WCP), a traditional Chinese medicine, possesses properties that can enhance renal fibrosis and provide kidney protection. Nonetheless, the connection between WCP and T cell infiltration and differentiation in LN remains poorly understood. The objective of this research was to assess the immunomodulatory impacts of WCP in LN mice and elucidate the underlying mechanism through in vivo and in vitro investigations. To investigate the impact and mechanism of WCP in MRL/lpr lupus-prone mice, WCP (1.5 g/kg/d), Bailing capsules (BC, 0.75 g/kg/d), and saline in equivalent quantities were administered to the mice over a period of 8 weeks. The therapeutic effects, T cell infiltration and differentiation of WCP on MRL/lpr mice were verified through ELISA, Hematoxylin-eosin (H&E), Periodic Acid Schiff (PAS) staining, immunofluorescence, Luminex analysis and flow cytometry. The mechanism by which WCP alleviates LN was investigated using tissues of mice, T cells and Mouse Podocyte Clone-5 (MPC-5) cells by transcriptomics, Western blot (WB), and Real-time quantitative polymerase chain reaction (RT-qPCR). We found that WCP improved LN in MRL/lpr mice by reducing urinary protein, creatinine, and serum auto antibodies, increasing complement 3 (C3) level, improving renal immunopathology and downregulating serum cytokines, including IFN-γ, IL-12, and RANTES. Notably, the infiltration of CD4+ and CD8+ T cells in the kidney was reduced by WCP. Similarly, the cell transwell co-culturation study showed that the WCP treated MPC-5 cells were weaker in inducing T cell migration. Consistent with this finding, our observations revealed that WCP could inhibit T cell-related chemokine expression in kidney and MPC-5 cells, as well as reduce the levels of TLR4, MYD88, phosphorylated-p38, phosphorylated-ERK, and phosphorylated-JNK. On the other hand, WCP was found to greatly inhibit the Th1 cells differentiation in vivo and in vitro. Cytokine-receptor induced Th1 cell differentiation pathway and PI3K-AKT pathway were the most enriched pathways based on differentially expressed genes (DEGs) enrichment analysis among different cell groups. Results from RT-qPCR and WB showed that WCP notably reduced the levels of IL-12, p-STAT4, IFN-γ, p-STAT1, p-PI3K, and p-AKT in T cells. WCP demonstrated positive immunomodulatory effects on LN disease, by decreasing the T cells infiltration through TLR4/MYD88/MAPK signaling pathway and inhibiting Th1 cells differentiation via IL-12-STAT4 and IFN-γ-STAT1 pathways, in addition to the PI3K-AKT pathway.